Clinical Trials for Adenocarcinoma of Lung Metastatic to Brain

Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases

NCT ID: NCT06483672

This clinical trial is looking at how well a new treatment, combining two medications called furmonertinib and anlotinib, works for patients with lung adenocarcinoma (a type of lung cancer) that ha...